financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Dollar General Insider Sold Shares Worth $367,061, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dollar General Insider Sold Shares Worth $367,061, According to a Recent SEC Filing
Dec 16, 2024 2:59 PM

05:32 PM EST, 12/16/2024 (MT Newswires) -- Emily C Taylor, Executive Vice President & Chief Merchandising Officer, on December 13, 2024, sold 4,740 shares in Dollar General ( DG ) for $367,061. Following the Form 4 filing with the SEC, Taylor has control over a total of 15,575 shares of the company, with 15,575 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/29534/000106299324020673/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Swiss watchmakers rise on optimism over possible reduction in Trump tariffs
Swiss watchmakers rise on optimism over possible reduction in Trump tariffs
Nov 11, 2025
ZURICH (Reuters) -Richemont and Swatch Group shares rose on Tuesday, after U.S. President Donald Trump said he was working with Switzerland on a deal to lower the 39% tariff rate it faces on exports. Swatch shares gained 4.2% in early trading, while Richemont shares were 2% higher. Both companies' shares had fallen after Trump announced the import duties on Swiss...
 Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study
Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study
Nov 11, 2025
03:41 AM EST, 11/11/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said late Monday its phase 2 study evaluating the efficacy, safety and tolerability of experimental drug, NBI-1070770, in adults with major depressive disorder did not meet the primary endpoint compared with placebo. The drug developer said the phase 2 study enrolled 73 adult patients with a diagnosis of...
 Aeva Technologies Insider Sold Shares Worth $3,362,282, According to a Recent SEC Filing
Aeva Technologies Insider Sold Shares Worth $3,362,282, According to a Recent SEC Filing
Nov 11, 2025
03:42 AM EST, 11/11/2025 (MT Newswires) -- Soroush Salehian Dardashti, Director, Chief Executive Officer, on November 10, 2025, sold 250,000 shares in Aeva Technologies ( AEVA ) for $3,362,282. Following the Form 4 filing with the SEC, Dardashti has control over a total of 3,978,263 common shares of the company, with 2,093,455 shares held directly and 1,884,808 controlled indirectly. SEC...
 Enterprise Products Partners Prices $1.65 Billion Debt Offering
Enterprise Products Partners Prices $1.65 Billion Debt Offering
Nov 11, 2025
03:39 AM EST, 11/11/2025 (MT Newswires) -- Enterprise Products Partners ( EPD ) said Monday that it has priced a $1.65 billion public debt offering. The offering consists of $300 million worth of 4.3% senior notes due 2028, $600 million of 4.6% senior notes due 2031, and $750 million of 5.2% senior notes due 2036 at 100.63%, 100.693%, and 101.185%...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved